SecBot SecBot

ESTA

ESTABLISHMENT LABS HOLDINGS INC.
Nasdaq· Orthopedic, Prosthetic & Surgical Appliances & Supplies· Inc. D8· CIK 0001688757 Healthcare & Medical Devices
$65.88 +0.10 (+0.14%)
Oct 27 4:00 PM ET · prev $65.78
Market cap
$1.9B
Small cap
Consensus
Buy
93% Buy or better · 15 analysts
Median target
🔒 Subscribers only
Next earnings
Oct 29
in 2 days · EPS est. −$0.23
1 year
+29.6%
from $50.81 · Oct 27
30 days
+0.8%
from $65.34
52-week range
$47.80–95.65
−31% from high · low Nov 3
Avg volume 20D
416.5K
shares / day
Short interest
🔒 Subscribers only
Insider net
−$33.4M
0 buyers · 2 sellers · since Mar 25
New fund stakes
3
Q2 2026 13F · 0 exits
Filing reports
8
analyzed by SecBot
SecBot read MIXED 2 reports · 90 days
Balance 0 bearish · 0 bullish · 1 mixed · 1 neutral oldest → newest, height = score
Avg score ·High conf. 2/2 ·Next Earnings date, Oct 29, 2026
Strongest NEUTRAL Establishment Labs extended its exclusive medical-grade silicone supply agreement with NuSil Technology…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersBEARISH

    2 insiders sold $33.4M.

  • InstitutionsBULLISH

    Q2 2026: 34 added (3 new), 15 trimmed or exited. Largest new: Price T Rowe Associates /Md/ $131.6M, Rubric Capital Management $59.1M.

  • AnalystsBULLISH

    14 of 15 rate it Buy or better.

  • EstimatesRISING

    Current-quarter EPS estimate −$0.235 → −$0.230 over 90 days. 1 up, 1 down in 30 days.

  • TrendDOWNTREND

    2% below its 50-day average.

Who's buying

13F· Q2 2026
3
new positions
0
exits
$203.1M
in new stakes
FundMoveSharesValue
BlackRock, Inc.DOUBLED1,582,005$135.8M
PRICE T ROWE ASSOCIATES INC /MD/NEW1,533,497$131.6M
Rubric Capital Management LPNEW688,325$59.1M
BANK OF AMERICA CORP /DE/ADD608,040$52.2M
D. E. Shaw & Co., Inc.ADD566,910$48.6M
UBS Group AGDOUBLED548,960$47.1M
STATE STREET CORPDOUBLED455,315$39.1M
GEODE CAPITAL MANAGEMENT, LLCDOUBLED386,142$33.1M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

15 analysts
Buy 93% rate it Buy or better
Strong Buy6Buy8Hold1Sell0Strong Sell0

Fresh Price Targets

Analyst price targets updated within the last 24 hours are for subscribers only.

Subscribe for Full Access
Recent actions
DateFirmActionRating
Oct 26, 2026🔒 Fresh data, subscribers only
MAINTAIN
MAINTAIN
Oct 15, 2026TD Cowen
REITERATE
REITERATEBuy
Sep 1, 2026BTIG
REITERATE
REITERATEBuy
Aug 13, 2026Citigroup
UPGRADE
UPGRADEBuy
Aug 7, 2026JP Morgan
MAINTAIN
MAINTAINOverweight
Aug 6, 2026Needham
MAINTAIN
MAINTAINBuy

Insider ledger

Form 4
$0
bought · 0 insiders
$33.4M
sold · 2 insiders
DateInsiderTypeValue
Sep 30, 2026
SCHUTTER EDWARD J
Director
AWARD$16.2K
Sep 30, 2026
Gillin Leslie
Director
AWARD$16.8K
Sep 30, 2026
Custin Ann
Director
AWARD$19.3K
Sep 30, 2026
LEWIN NICHOLAS SHERIDAN
Director
AWARD$25.0K
Sep 30, 2026
Slotkin Bryan
Director
AWARD$16.2K
Aug 20, 2026
Caldini Filippo
Chief Executive Officer
TAX W/H$48.8K
Jun 30, 2026
Slotkin Bryan
Director
AWARD$16.2K
Jun 30, 2026
SCHUTTER EDWARD J
Director
AWARD$18.5K

Earnings setup

Estimates
Oct 29
reports in 2 days
−$0.23
EPS estimate, this quarter
+2%
estimate change, 90 days
1↑ 1↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q-$0.23-$0.24–-$0.22+0.0%$66.8M
Next Q🔒 Fresh data, subscribers only
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only

Short side

FINRA· Oct 15, 2026
🔒 Subscribers only
shares short
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 15, 2026 SEC
Establishment Labs extended its exclusive medical-grade silicone supply agreement with NuSil Technology through…
8-K — Impact 3/10
Sep 30, 2026 Insider
SCHUTTER EDWARD J was granted 253 shares
Director @ $64.17 ($16.2K)
Sep 30, 2026 Insider
Gillin Leslie was granted 262 shares
Director @ $64.17 ($16.8K)
Sep 30, 2026 Insider
Custin Ann was granted 301 shares
Director @ $64.17 ($19.3K)
Aug 6, 2026 SEC
Establishment Labs reported Q2 2026 revenue of $67.5M (+31.7% YoY, beating $65.8M consensus) and raised full-year…
8-K — Impact 6/10
Aug 6, 2026 Earnings calendar
ESTA Q2 2026 Earnings Scheduled — 2026-08-06
Jun 30, 2026 Inst.
BlackRock, Inc. — DOUBLED
1,582,005 shares ($135.8M)
Jun 30, 2026 Inst.
PRICE T ROWE ASSOCIATES — NEW
1,533,497 shares ($131.6M)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Oct 29, 2026
Earnings date
ESTA Q3 2026 Earnings Before Market Open — 2026-10-29
Recent
Aug 6, 2026
Earnings date
ESTA Q2 2026 Earnings Scheduled — 2026-08-06
Jun 30, 2026
Short interest
Short Interest: ESTA up 23% to 4.8M shares
Settlement 2026-06-30 | Days to cover: 4.22 | ≈16.20% of shares outstanding (est.)
May 7, 2026
Short interest
FTD: ESTA — 25,176 shares ($1.9M) failed to deliver
Settlement: 20260507, Price: $74.54, FTD Value: $1,876,619.04, ESTABLISHMENT LABS HLDGS INC C
May 6, 2026
Earnings date
ESTA Q1 2026 Earnings Scheduled — 2026-05-06
Feb 24, 2026
Earnings date
ESTA Q4 2025 Earnings Before Market Open — 2026-02-24

SecBot reports

8 filings · 1 bullish · 1 bearish · 1 mixed · 5 neutral
All ESTA filing & press-release reports (8)